Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 400 Shares
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock on March 13, 2025, at a price of $63.33 per share.
Summary
- On March 13, 2025, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock.
- The transaction was executed at a price of $63.33 per share.
- Following the transaction, Cook directly owns 80,545 shares of ANI Pharmaceuticals.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on September 17, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a standard insider transaction under a pre-existing 10b5-1 plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider transaction. Insider sales can sometimes be interpreted negatively by the market, but the existence of a 10b5-1 plan suggests the sale was pre-planned and not based on current inside information.
Stakeholder Impact
- The sale of shares by a company executive could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| September 17, 2024 | Date the reporting person adopted a Rule 10b5-1 trading plan |
| 03/13/2025 | Date of transaction: sale of 400 shares of common stock |
| 03/14/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.